How to manage a patient with mixed respiratory acidosis and metabolic alkalosis as indicated by arterial blood gas (ABG) results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The patient with mixed respiratory acidosis and metabolic alkalosis, as indicated by the ABG results (pH 7.44, PCO2 61, HCO3 42), should be managed by addressing the underlying causes of both conditions simultaneously, with a focus on improving ventilation and correcting the metabolic alkalosis. The patient's ABG results indicate a mixed disorder, with respiratory acidosis (elevated PCO2) and metabolic alkalosis (elevated HCO3). To manage this patient, it is essential to identify and treat the underlying causes of both conditions.

  • The respiratory acidosis can be addressed by improving ventilation, which may involve the use of bronchodilators like albuterol 2.5-5 mg via nebulizer or BiPAP/CPAP if indicated, as suggested by the BTS guideline for oxygen use in adults in healthcare and emergency settings 1.
  • The metabolic alkalosis can be corrected by addressing volume status with isotonic fluids like normal saline at 10-20 ml/kg if the patient is volume depleted, discontinuing diuretics if possible, and considering potassium chloride supplementation (typically 10-20 mEq IV or 20-40 mEq orally) if hypokalemia is present.
  • Continuous monitoring of ABGs is crucial, targeting pH normalization toward 7.35-7.45. The BTS guideline for oxygen use in adults in healthcare and emergency settings 1 and the BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults 1 provide valuable guidance on managing patients with respiratory acidosis and hypercapnic respiratory failure.
  • The guideline recommends careful monitoring of patients with COPD for hypercapnic respiratory failure and avoiding excessive oxygen use, which can worsen respiratory acidosis 1.
  • For patients with hypercapnic respiratory failure, the guideline suggests targeting an oxygen saturation of 88-92% and considering non-invasive ventilation (NIV) or invasive ventilation if respiratory acidosis persists 1.

From the Research

Arterial Blood Gas (ABG) Results

The given ABG results are: pH 7.44, PCO2 61, HCO3 42. These results indicate a mixed respiratory acidosis and metabolic alkalosis.

Mixed Respiratory Acidosis and Metabolic Alkalosis

  • Respiratory acidosis is characterized by an elevated PCO2 level (61 mmHg), which is above the normal range of 35-45 mmHg 2.
  • Metabolic alkalosis is indicated by an elevated HCO3 level (42 mmol/L), which is above the normal range of 22-28 mmol/L 3.
  • The elevated pH (7.44) suggests that the metabolic alkalosis is partially compensating for the respiratory acidosis.

Management

  • Treatment of mixed respiratory acidosis and metabolic alkalosis involves addressing the underlying causes of both disorders 3.
  • For respiratory acidosis, treatment may involve improving ventilation, such as through the use of non-invasive or invasive mechanical ventilation 2.
  • For metabolic alkalosis, treatment may involve volume resuscitation and repletion of potassium deficits 3.
  • Aggressive lowering of the pH is usually not necessary, and the use of bicarbonate to correct the acidemia is not recommended 3.

Considerations

  • The use of permissive hypercapnia to prevent barotrauma has become the standard of care in patients with respiratory acidosis 3.
  • In patients with severe respiratory acidosis, the use of extracorporeal therapies to remove CO2 can be considered 3.
  • The management of mixed respiratory acidosis and metabolic alkalosis requires a thorough understanding of the underlying causes and pathophysiology of both disorders 2, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Respiratory Acidosis and Respiratory Alkalosis: Core Curriculum 2023.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023

Research

Acid-Base Disorders in the Critically Ill Patient.

Clinical journal of the American Society of Nephrology : CJASN, 2023

Research

Evaluation and treatment of respiratory alkalosis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012

Research

Respiratory adjustment to chronic metabolic alkalosis in man.

The Journal of clinical investigation, 1968

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.